Alternatives to AbbVie
AbbVie is a Biotechnology tool: a global research-based biopharmaceutical company focused on developing advanced therapies for complex medical conditions. Here are the 60 closest alternatives, compared on pricing, features and what real users say.
The 20 closest Biotechnology companies to AbbVie
RejoniNot ratedElevating uterine health through innovative biomaterial therapies.
BiotechnologyHealthcareUpdated 7 Jul 2026
Galderma Group3.0 out of 5 (1)A global pure-play dermatology company focused on injectable aesthetics, dermatological skincare, and therapeutic medicine.
HealthcareBiotechnologyUpdated 10 May 2026
Immunyx PharmaNot ratedBiopharmaceutical company developing targeted neutrophil nanoparticle platform for chronic diseases.
Life SciencesBiopharmaceuticalUpdated 30 Aug 2026
Ipsen3.0 out of 5 (1)Global biopharmaceutical company focused on oncology, rare diseases, and neuroscience.
BiotechMedTechUpdated 30 Jun 2026
Ferring PharmaceuticalsNot ratedA global, research-driven biopharmaceutical group focused on reproductive medicine, maternal health, and other specialized therapeutic areas.
BiotechMedTechUpdated 22 Jun 2026- CHChemoCentryxNot rated
Biopharmaceutical company focused on developing orally administered therapeutics for inflammatory disorders and cancer.
BiotechDrug DiscoveryUpdated 3 Jul 2026
Moderna2.5 out of 5 (2)Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.
BiotechnologymRNA TechnologyUpdated 9 Jul 2026- JUJuno TherapeuticsNot rated
Biotechnology company focused on developing cancer immunotherapies.
BiotechnologyPharmaceuticalsUpdated 13 Sept 2026
Kite PharmaNot ratedBiotechnology company developing and commercializing cell therapies for cancer treatment.
BiotechnologyPharmaceuticalsUpdated 10 Jul 2026
CRISPR TherapeuticsNot ratedBiotechnology company developing transformative gene-based medicines using CRISPR/Cas9 gene editing technology.
BiotechnologyGene EditingUpdated 12 Aug 2026
Degron TherapeuticsNot ratedClinical-stage biotechnology company advancing molecular glue degrader (MGD) medicines.
BiotechnologyPharmaceuticalsUpdated 13 Sept 2026
Seaport TherapeuticsNot ratedDeveloping novel therapeutics to restore gut lymphatic function.
BiotechnologyPharmaceuticalsUpdated 13 Sept 2026
InfinimmuneNot ratedDeveloping human-derived antibodies for inflammatory diseases and cancer using AI and proprietary platforms.
BiotechnologyPharmaceuticalsUpdated 19 Aug 2026
CellCentricNot ratedA clinical-stage biotechnology company developing inobrodib as a first-in-class, oral p300/CBP inhibitor for the treatment of multiple myeloma.
BiotechnologyPharmaceuticalsUpdated 8 May 2026
Supernus PharmaceuticalsNot ratedBiopharmaceutical company developing and commercializing CNS disease treatments.
BiotechnologyPharmaceuticalsUpdated 4 May 2026- CRCreate MedicinesNot rated
Developing in vivo immunotherapies for autoimmune diseases and cancer.
BiotechnologyHealthTechUpdated 24 May 2026
EnteromeNot ratedClinical-stage biopharmaceutical company developing microbiome-derived immunotherapies for cancer and immune diseases.
BiotechnologyDrug DiscoveryUpdated 1 May 2026
AdcendoNot ratedDeveloping first-and best-in-class antibody-drug conjugates (ADCs) for cancers with high unmet medical need.
BiotechnologyPharmaceuticalsUpdated 5 Aug 2026
CelerionNot ratedA global leader in clinical pharmacology and bioanalytical sciences.
BiotechnologyPharmaceuticalsUpdated 1 May 2026
MironidNot ratedBiopharmaceutical company developing novel small-molecule therapeutics for rare kidney diseases, particularly Autosomal Dominant Polycystic Kidney Disease (ADPKD).
BiotechnologyPharmaceuticalsUpdated 8 Aug 2026
Showing the 20 closest matches. See the rest on the AbbVie profile.